The demand for transplant diagnostic products is expected to increase mainly due to factors such as increasing public and private funding for targeted research activities, increasing epidemic burden, increasing transplant procedures and technological advancements in transplant diagnostics.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
Human white blood cell antigen (HLA) types determine whether patients and donors are eligible for cord blood or bone marrow transplantation. Human white blood cell antigen (HLA) is a protein found in our body.
Market Segmentation
Based on the product, the HLA typing for the transplants market is segmented into reagents consumables, instruments, and software services. The reagents consumables segment held the largest share of the global HLA typing for the transplants market. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and the growing adoption of transplant diagnostic techniques (includes HLA typing) in related research studies are driving the growth of this segment.
Based on technology, the HLA typing for the transplants market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period.
Based on the application, the HLA typing for the transplants market is categorized into diagnostic and research applications. Diagnostic applications accounted for the largest share of the HLA typing for the transplants market. Increasing adoption of molecular assay procedures for pathogen detection histocompatibility testing, and the rising incidence of chronic diseases, and supportive government regulations to increase organ donations across major healthcare markets are the key factors supporting the growth of this application segment
Regional Analysis
North America accounted for the largest share of the HLA typing for the transplants market followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products (includes HLA typing) coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.
Expected Revenue Growth:
[193 Pages Report] The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742
Key Market Players
Some of the players in the HLA typing for transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary)
Thermo Fisher Scientific is the leading player in the global HLA typing for the transplants market. The company has a broad range of automated instruments for antibody screening and analysis, semi-automated systems for serological assays, standalone systems reagents for molecular and non-molecular assay procedures, including HLA typing products for transplant.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of the five major companies
- Company Information: Detailed analysis and profiling of additional market players (Up to 5)
Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
